#FindCKD - Twitter Hashtag

Sayna Norouzi, MD, FASN

@SaynaNorouzi

about 2 months ago

eGFR data in patients with glomerular diseases #FINDCKD #GlomConHawaii @VladoPerkovic @GlomCon 🔥🙌🏻

0

19

9

1

943

Prof Liz B 🇬🇧🇮🇱🇺🇦🇵🇸

@kidneydoc101

4 months ago

@brendonneuen But… we mustn’t lose sight of treating the underlying disease - might prevent the #CKD altogether! #FINDCKD #ERA26

0

5

2

0

634

AncaSt @AncaSt13

4 months ago

Another amazing encounter at #ERA26 What a great time to be a nephrologist ✨❤️ #finerenone #findCKD @dianarodespi @VladoPerkovic

AncaSt13's tweet photo. Another amazing encounter at #ERA26
What a great time to be a nephrologist ✨❤️
#finerenone #findCKD @dianarodespi @VladoPerkovic https://t.co/QFwfDkhgpN

0

11

2

0

274

AncaSt @AncaSt13

4 months ago

Being in #latebreakingclinicaltrials at #ERA26 feels like a Taylor Swift concert. Loving every second ❤️✨ #finerenone #findCKD #obinutuzumab #rituximabinnephroticGN #aHUS

0

8

2

1

286

Milagros Flores @dra_miliflores

4 months ago

#FindCKD #ERA26

Raquel Barba Teba 🦋 @DrBarbaTeba

4 months ago

#ERA26 @ERAkidney Results FIND-CKD: 💊Difference of 0.7 ml/min per year difference with placebo. 💊Composite kidney-CV outcome: HR 0.77 (0.6-0.99) 💊UACR outcome: reduction of albuminuria by 35% at month 6

DrBarbaTeba's tweet photo. #ERA26 @ERAkidney
Results FIND-CKD:
💊Difference of 0.7 ml/min per year difference with placebo.
💊Composite kidney-CV outcome: HR 0.77 (0.6-0.99)
💊UACR outcome: reduction of albuminuria by 35% at month 6 https://t.co/TPIQZvcuVG

1

8

1

0

520

0

3

0

152

Arunkumar @Arunkr_Dr

4 months ago

@ERAkidney @VladoPerkovic @HeerspinkHiddo @brendonneuen @AgarwalRajivMD 📚 Beyond the headline results of #FINDCKD, don't miss the science behind the study. 📱 Scan the QR codes below and dive into the data. #ERA26 #Nephrology #CKD #Finerenone

Arunkr_Dr's tweet photo. @ERAkidney @VladoPerkovic @HeerspinkHiddo @brendonneuen @AgarwalRajivMD 📚 Beyond the headline results of #FINDCKD, don't miss the science behind the study.

📱 Scan the QR codes below and dive into the data.

#ERA26 #Nephrology #CKD #Finerenone https://t.co/UGuMZhtCIh

0

5

3

2

655

Arunkumar @Arunkr_Dr

4 months ago

@ERAkidney @VladoPerkovic @HeerspinkHiddo 57% of #FINDCKD participants had glomerular disease. 📉 Slower eGFR decline with finerenone 📉 Lower albuminuria 📉 Fewer kidney-CV events Benefits appeared consistent across IgAN, FSGS, MN and other GN subtypes. #ERA26 #GlomerularDisease

Arunkr_Dr's tweet photo. @ERAkidney @VladoPerkovic @HeerspinkHiddo 57% of #FINDCKD participants had glomerular disease.

📉 Slower eGFR decline with finerenone
📉 Lower albuminuria
📉 Fewer kidney-CV events

Benefits appeared consistent across IgAN, FSGS, MN and other GN subtypes.

#ERA26 #GlomerularDisease https://t.co/OHj6ATPSjU

1

10

3

0

586

Milagros Flores @dra_miliflores

4 months ago

Otro análisis #FINDCKD 📍903 pacientes 📍80% con biopsia renal 🔹Resultados?📉TFGe slope total 🎯¿cuál se benefició más? IgAN ➡️ HR 0.82 FSGS ➡️ HR 0.60 Membranosa ➡️ HR 0.77 Entonces, podría finerenona convertirse en el siguiente pilar de las GN!? #era26

dra_miliflores's tweet photo. Otro análisis #FINDCKD
📍903 pacientes
📍80% con biopsia renal
🔹Resultados?📉TFGe slope total

🎯¿cuál se benefició más?
IgAN ➡️ HR 0.82
FSGS ➡️ HR 0.60
Membranosa ➡️ HR 0.77

Entonces, podría finerenona convertirse en el siguiente pilar de las GN!? #era26 https://t.co/TbodtcASPj

0

3

1

364

Arunkumar @Arunkr_Dr

4 months ago

@ERAkidney @VladoPerkovic 🚨 #FINDCKD results #ERA26 🔹 Finerenone slowed CKD progression in non-diabetic CKD 🔹 Primary endpoint met (total eGFR slope) 🔹 Significant reduction albuminuria (~37% vs placebo) 🔹 56% achieved ≥30% UACR reduction vs 24% placebo 🔹 Reduced composite kidney-CV events(HR 0.77)

Arunkr_Dr's tweet photo. @ERAkidney @VladoPerkovic 🚨 #FINDCKD results #ERA26
🔹 Finerenone slowed CKD progression in non-diabetic CKD
🔹 Primary endpoint met (total eGFR slope)
🔹 Significant reduction albuminuria (~37% vs placebo) 🔹 56% achieved ≥30% UACR reduction vs 24% placebo
🔹 Reduced composite kidney-CV events(HR 0.77) https://t.co/JR89ZwKrAX

1

14

5

0

555

Arunkumar @Arunkr_Dr

4 months ago

📊 #FINDCKD Study Design #ERA26 🔹 Phase III, multicentre, randomized, double-blind, placebo-controlled trial 🔹 Enrolled patients with non-diabetic CKD at risk of progression despite optimized ACEi/ARB therapy 🔹 3,231 screened; 1,584 randomized (1:1)

Arunkr_Dr's tweet photo. 📊 #FINDCKD Study Design #ERA26

🔹 Phase III, multicentre, randomized, double-blind, placebo-controlled trial
🔹 Enrolled patients with non-diabetic CKD at risk of progression despite optimized ACEi/ARB therapy
🔹 3,231 screened; 1,584 randomized (1:1) https://t.co/9TEtGIFj7B

1

7

5

0

405

Arunkumar @Arunkr_Dr

4 months ago

🚨 High-Impact Clinical Trial at #ERA26 FIND-CKD explores whether the benefits of finerenone can extend beyond DKD to the large population with non-diabetic CKD #FINDCKD #CKD #Nephrology

Arunkr_Dr's tweet photo. 🚨 High-Impact Clinical Trial at #ERA26

FIND-CKD explores whether the benefits of finerenone can extend beyond DKD to the large population with non-diabetic CKD

#FINDCKD #CKD #Nephrology https://t.co/tpbtZZgeea

1

35

12

10

2K

Ahmed Bennis MD 🫀

@drbennisahmed

4 months ago

📢 New design publication! The #FINDCKD trial — the first Phase 3 study of finerenone in patients with non-diabetic #CKD — is now published in @NDT_ERA. 1,584 patients randomized across 24 countries. Primary endpoint: total eGFR slope over 32 months. #Nephrology #Finerenone

drbennisahmed's tweet photo. 📢 New design publication! The #FINDCKD trial — the first Phase 3 study of finerenone in patients with non-diabetic #CKD — is now published in @NDT_ERA. 1,584 patients randomized across 24 countries. Primary endpoint: total eGFR slope over 32 months. #Nephrology #Finerenone https://t.co/UUssnu7URg

0

43

14

11

4K

Brendon Neuen @brendonneuen

over 3 years ago

FIND-CKD is fully recruited! Assessing the effects of finerenone in 1⃣5⃣8⃣4⃣ patients with non-diabetic CKD Primary outcome: Total GFR slope to 32 months Thanks to all investigators & patients worldwide who are involved in the #FINDCKD trial https://t.co/NvYeaWpT6y